Adult Trauma Centers RE-AIM at Gun Safety
Launched by JOHNS HOPKINS UNIVERSITY · Mar 4, 2024
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Electronic Medical Record (EMR) Participants:
- Inclusion Criteria:
- • trauma patients admitted to adult trauma inpatient services at participating institutions
- Exclusion Criteria:
- • none
- • Patient participants
- Inclusion Criteria:
- • at least 18 years of age;
- • admitted to a participating trauma service for an injury;
- • fluent in English or Spanish;
- • able to provide informed consent.
- Exclusion Criteria:
- • prisoner or in police custody;
- • admitted due to suicide attempt
- • any acute conditions that would preclude provision of informed consent or assent (i.e., acute psychosis, altered mental status, cognitive impairment).
- • Staff participants
- Inclusion Criteria:
- • trauma service physician, physician assistant, nurse practitioner, nurse or social worker at participating pediatric trauma center
- Exclusion Criteria:
- • none
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Katherine Hoops, MD, MPH
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported